Indegene Ltd's Q3FY25 Quarter Results
- 3d ago
Result Summary
- Indegene Ltd reported a 7.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 10.4%.
- Its expenses for the quarter were up by 4.7% QoQ and 10.3% YoY.
- The net profit increased 19.6% QoQ and increased 11.4% YoY.
- The earnings per share (EPS) of Indegene Ltd stood at 4.5 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 758.10 | 708.20 | 686.45 | 7.0% | 10.4% |
Total Expenses | 611.80 | 584.10 | 554.44 | 4.7% | 10.3% |
Profit Before Tax | 146.30 | 124.10 | 132.01 | 17.9% | 10.8% |
Tax | 36.60 | 32.40 | 33.50 | 13.0% | 9.3% |
Profit After Tax | 109.70 | 91.70 | 98.50 | 19.6% | 11.4% |
Earnings Per Share | 4.50 | 3.80 | 0.00 | 18.4% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Indegene Ltd is a prominent player in the healthcare solutions industry, specializing in providing comprehensive services that span across pharmaceutical, biotechnology, and medical device sectors. The company offers a range of solutions including medical, marketing, and analytics services, designed to enhance healthcare delivery and patient outcomes. Indegene is known for leveraging technology and innovation to deliver value to its clients, positioning itself as a trusted partner in the healthcare ecosystem. While specific recent developments are not available within the provided data, Indegene's focus on digital transformation and data-driven insights remains central to its operational strategy.
Revenue
In the third quarter of FY25, Indegene Ltd reported a total income of ₹758.10 crores, reflecting a quarter-over-quarter (QoQ) increase of 7.0% from ₹708.20 crores in Q2FY25. Additionally, the year-over-year (YoY) growth compared to Q3FY24 was 10.4%, with the total income previously recorded at ₹686.45 crores. This upward trajectory in revenue indicates a consistent improvement in the company's financial inflows over the analyzed periods. The revenue growth suggests a positive momentum in Indegene's business operations, potentially driven by an increase in demand for its healthcare solutions and services.
Profitability
The company's profitability metrics for Q3FY25 highlight a profit before tax of ₹146.30 crores, which marks a 17.9% QoQ increase from ₹124.10 crores in Q2FY25, and a YoY increase of 10.8% compared to ₹132.01 crores in Q3FY24. The profit after tax in Q3FY25 was recorded at ₹109.70 crores, showing a significant QoQ growth of 19.6% from ₹91.70 crores in the previous quarter and an 11.4% YoY increase from ₹98.50 crores in Q3FY24. These figures are complemented by the earnings per share (EPS) of ₹4.50 in Q3FY25, which rose by 18.4% QoQ from ₹3.80 in Q2FY25. This increase in both profit and EPS over the quarters and year indicates strong profitability performance.
Operating Metrics
Indegene Ltd's operational expenses reflect a growth in total expenses, which amounted to ₹611.80 crores in Q3FY25, a 4.7% QoQ increase from ₹584.10 crores in Q2FY25, and a 10.3% YoY increase from ₹554.44 crores in Q3FY24. The company's tax expenses for Q3FY25 were ₹36.60 crores, representing a 13.0% QoQ increase from ₹32.40 crores in Q2FY25 and a 9.3% YoY rise from ₹33.50 crores in Q3FY24. These operational metrics indicate an escalation in both expenses and tax obligations over the observed periods. The financial data suggests that Indegene Ltd is experiencing growth in its operational scale, reflected by the increased expenses, while maintaining a robust profit margin.
